Inequalities in coronary heart disease treatment
Professor Azeem MajeedUniversity College London
Outline of talk Why CHD is important Inequalities in CHD Inequalities in treatment Possible explanations Proposed solutions
Why is CHD important?
Mortality: Numbers CHD is the single most common cause
of death in both men and women. One in four men and one in six women
die from CHD (about 125,000 deaths in the UK in 2000)
CHD is also the commonest cause of premature death (about 45,000 deaths)
Mortality: International Death rate from CHD in the UK is
among the highest in the world Although death rates have fallen in
the UK, rates have fallen more quickly in many other countries
Within UK, rates are highest in Scotland, Northern Ireland and Northern England
Morbidity: Prevalence Calendar year 1998 210 general practices in England &
Wales, part of GPRD 1.3 million patients
CHD: Prevalence per 1,000
0
50
100
150
200
250
35-44 45-54 55-64 65-74 75-84 85+
MenWomen
Inequalities in CHD
Inequalities: Type Social Class Geographical Ethnic Group
SMR: Social Class Standardised mortality ratios Adjust for age (& sex) Average for population = 100 Values > 100 imply more deaths
than expected Values < 100 imply less deaths
than expected
SMR: Men by Social Class
020406080
100120140160180200
I I I I I IN II IM IV V
Prevalence: Area Variations
0
5
10
15
20
25
30
35
40
Q1 Q2 Q3 Q4 Q5
Inequalities in CHD Treatment
CHD Treatments Lifestyle changes Drugs for angina Drugs to reduce risk of acute
events: e.g. aspirin & statins Control of risk factors: e.g.
diabetes, high blood pressure Interventions: Angioplasty & CABG
Age & sex differences Calendar year 1998 210 general practices in England &
Wales, part of GPRD 1.3 million patients
Statins in CHD Patients
0
10
20
30
40
50
60
35-44 45-54 55-64 65-74 75-84 85+
MenWomen
Aspirin in CHD Patients
0
10
20
30
40
50
60
70
35-44 45-54 55-64 65-74 75-84 85+
MenWomen
Statins: Area Variations
0
5
10
15
20
25
30
Q1 Q2 Q3 Q4 Q5
Study in Wandsworth PCT 63 general practices September 2000 - May 2001 Population 378,000 6778 patients with CHD Some evidence that sex
differences narrowing
Prescribing in CHD Patients
0
10
20
30
40
50
60
70
Women Men
History of MI &prescribed beta-blockerAngina &prescribed beta-blockerHistory of MI &prescribed ACE-inhibitorPrescribed statin
Prescribed aspirin
Secondary & Tertiary Care Several studies have examined
equity of access to care Thrombolysis Angiography Angioplasty & CABG Drug treatment on discharge
Older studies Studies carried out in early - mid
1990s Age, sex and socio-economic
differences present Women, elderly, deprived had
poorer access to specialist investigation & treatment
SW Thames: Early 1990s Admissions for CHD in one year Proportion of admissions in which
angiography carried out Proportion of admissions in which
coronary artery bypass graft (CABG) or percutaneous transluminal angioplasty (PTCA) carried out
Admissions with angiography
0
5
10
15
20
25
35-44 45-54 55-64 65-74 75-84 85+
MenWomen
Admission with CABG/PTCA
0
2
4
6
8
10
12
14
35-44 45-54 55-64 65-74 75-84 85+
MenWomen
Newer studies Many studies carried out in late
1990s & early 2000s Show a narrowing of gap between
men & women and elderly & younger patients
Possibly still some socio-economic differences in access to specialist care
Possible Explanations Patient & society Clinical trials Primary care Secondary care Tertiary care
Proposed solutions Greater awareness among clinicians
and patients More women and elderly in clinical
trials National service frameworks Review of health inequalities Clinical governance Better use of NHS data for monitoring
Conclusions Even in a free health care system
like the NHS, some groups have poorer access to care than others
Greater awareness among patients, clinicians, policymakers
Interventions in place to reduce inequalities & discrimination